Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 14

Expert digest

Weight After Stopping Rybelsus

Weight regain can follow semaglutide withdrawal, but direct evidence after stopping oral Rybelsus remains limited and needs careful context.

28 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

CX11 Data Behind Corxel's SPAC Deal

Corxel's SPAC plan rests partly on a company-reported CX11 Phase 2 result. The registry confirms the study design, but not the result.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

China semaglutide equivalence trial

A 481-person Chinese trial found equivalent 32-week HbA1c lowering for two study semaglutide injections in people using metformin.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

GLP-1 drugs and arrhythmia meta-analysis

A 2026 network meta-analysis linked subcutaneous semaglutide with fewer reported atrial-fibrillation events, but it cannot establish an AF treatment.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

GLP-1 Weight Loss and Endocrine Therapy

A 269-patient retrospective cohort reports GLP-1-associated weight change during adjuvant endocrine therapy for breast cancer.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Expert digest

Rapid Weight Gain Before Semaglutide

Rapid unintentional weight gain needs assessment before a semaglutide decision because medicines, medical conditions, and fluid can contribute.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Retatrutide side effects in trials

Retatrutide trials most often report gastrointestinal events and a dose-related heart-rate increase, but there is no approved safety label yet.

27 Oct 2026 · PeptideMethods Editorial Team · 5 min read
Expert digest

Semaglutide 1 mg Versus 2 mg

Semaglutide 2 mg produced modest extra glucose lowering versus 1 mg in one diabetes trial, but pen strengths and indications still govern use.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Semaglutide and Concomitant Medicines

A Danish register study found shifts in several prescribing categories after semaglutide initiation, but it cannot establish causation.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Expert digest

Does Semaglutide Change Food Enjoyment?

Semaglutide studies find lower energy intake and cravings, but they do not identify a universal list of foods or drinks people will still enjoy.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

How to Read Semaglutide Progress Photos

A semaglutide before-and-after image can describe one person's experience, but it cannot establish cause, safety, product identity, or a result for others.

27 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

How CJC-1295 Works

CJC-1295 signals the pituitary to release growth hormone, while its studied albumin-binding design extends exposure for days.

26 Oct 2026 · PeptideMethods Editorial Team · 4 min read